​​​2018 Excellence in Oncology Award​

Oncology Times is proud to announce the winners of the 2018 Excellence in Oncology Award​; an exciting contest designed to recognize the wonderful research, dedication, and dramatic impact on patients (and their families) that occur every day in oncology.

Original.00130989-201805200-00001.F2-1.jpgWINNER: Earning Praise for CAR T-Cell Therapy​

Sattva Neelapu, MD, Professor of Lymphoma & Myeloma at The University of Texas MD Anderson Cancer Center in Houston, and Frederick Locke, MD, Vice Chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy at Moffitt Cancer Center in Tampa, share the honors as winners of the 2018 Excellence in Oncology award for their research focusing on CAR T-cell therapy for adult patients with diffuse large B-cell lymphoma.

FIRST RUNNER-UP: The Microbiome & Metastatic Melanoma

The results of a new study showed the type and abundance of certain bacteria in a patient’s gut can predict how well they will respond to immunotherapy for metastatic melanoma. The discovery, which validates an approach to cancer treatment previously only seen in the preclinical stage, was made by a multidisciplinary team led by Jennifer Wargo, MD, Associate Professor of Surgical Oncology and Genomic Medicine, and co-lead author, Vancheswaran (Deepak) Gopalakrishnan, MPH, PhD, The University of Texas MD Anderson Cancer Center in Houston.

SECOND RUNNER-UP: The Improvement of Lymph Node Mapping in Endometrial Cancer

Robert W. Holloway, MD, FACOG, FACS, and Sarfraz Ahmad, PhD, FAACC, at the Florida Hospital Cancer Institute, aimed at improving imaging to detect metastatic disease in pelvic lymph nodes of women with endometrial cancer. Through this work, data have shown that, by using isosulfan blue dye (ISB) in combination with indocyanine green dye and near infrared, they detected significantly more sentinel lymph nodes and more lymph node metastasis than ISB-alone.​

HONORABLE MENTION: Study Validates Safety & Efficacy of Scalp Cooling Technology

Recognizing that the results varied in previous, non-randomized trials using scalp cooling devices to treat alopecia secondary to chemotherapy, a team of researchers led by Julie R. Nangia, MD, Assistant Professor of Medicine at Baylor College of Medicine in Houston, resolved to conduct the world's first randomized study to help provide more women access to scalp cooling technology.​